跳至主要内容
临床试验/ISRCTN58194927
ISRCTN58194927已完成不适用

Randomised, double blind, placebo controlled trial of intramyocardial injection of autologous bone marrow cells in no-option patients with refractory angina pectoris and documented ischaemia

eiden University Medical Centre (LUMC) (The Netherlands)0 个研究点目标入组 40 人开始时间: 2006年1月27日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Severe refractory angina despite optimal medical therapy
  • 2. Reversible ischaemia on gated-single photon emission computed tomography (SPECT)
  • 3. Not a candidate for (repeat) revascularisation (coronary artery bypass graft [CABG] or percutaneous coronary intervention [PCI])
  • 4. Male or female, greater than 18 years old
  • 5. Patients must be stable (e.g. not be in a setting of life-threatening heart failure)
  • 6. Written informed consent

排除标准

  • 1. Acute myocardial infarction, PCI or CABG within 6 months of enrolment in the study
  • 2. History of malignancy (except low grade and fully resolved non-melanoma skin malignancy)
  • 3. Unexplained haematological or biochemical abnormalities
  • 4. Concurrent participation in a study using an experimental drug or an experimental procedure within 6 months before the injection procedure
  • 5. Other severe concurrent illnesses (e.g. active infection, aortic stenosis, renal failure)
  • 6. Bleeding diathesis or human immunodeficiency virus (HIV) infection
  • 7. Inability to follow the protocol and comply with follow-up requirements

研究者

发起方
eiden University Medical Centre (LUMC) (The Netherlands)

相似试验